Page last updated: 2024-10-27

flurbiprofen and Osteoporosis

flurbiprofen has been researched along with Osteoporosis in 3 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"Nitroflurbiprofen is a nitrosylated flurbiprofen analog under development by NicOx for the potential treatment of urinary incontinence, Alzheimer's disease (AD) and the prevention and treatment of accelerated bone resorption associated with disorders such as osteoporosis, inflammatory joint disease and Paget's disease."4.82Nitroflurbiprofen (NicOx). ( Scatena, R, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scatena, R1
Sass, DA1
Rucinski, B1
Bryer, HP1
Mann, GN1
Yuan, Z1
Ma, Y1
Jee, WS1
Epstein, S1
Aoyagi, M1
Sasaki, T1
Ramamurthy, NS1
Golub, LM1

Reviews

1 review available for flurbiprofen and Osteoporosis

ArticleYear
Nitroflurbiprofen (NicOx).
    Current opinion in investigational drugs (London, England : 2000), 2004, Volume: 5, Issue:5

    Topics: Alzheimer Disease; Animals; Arthritis; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Flurbipr

2004

Other Studies

2 other studies available for flurbiprofen and Osteoporosis

ArticleYear
Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Bone, 1996, Volume: 19, Issue:4

    Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood

1996
Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations.
    Bone, 1996, Volume: 19, Issue:6

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone and Bones; Bone Remodeling; Drug Therapy, Com

1996